InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,040.04
(
1.10%
)
US TECH 100
21,199.66
(
1.36%
)
Dow Jones
43,297.03
(
0.91%
)
Brent Oil
73.29
(
0.80%
)
Bitcoin
98,179.62
(
3.68%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: poorgradstudent post# 22622

Monday, 10/01/2012 1:21:03 PM

Monday, October 01, 2012 1:21:03 PM

Post# of 80490
Although the MTD has not been reached, at least in ALK+ it certainly appears that 113 offers a stronger response and lower tox than LDK378 (which btw showed DLT at 400mg which also happens to be the active dose....not a good thing)

As far as EGFR goes it is too early to know, however, the PK data looked really good to me...especially in the 8L58R and T790M mutations. Your thoughts? http://bit.ly/V6K65V http://bit.ly/O0DRxG
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up